2021 annual financial data
BridgeBio Pharma 2021 Operating margin
BridgeBio Pharma 2021 operating margin with verified reported values.
Direct answer
Operating margin was -827.12%.
Operating income was -576,632,000 USD and net income was -562,539,000 USD.
Operating cash flow was -497,934,000 USD.
Verified data
- Revenue
- 69,716,000 USD
- Operating income
- -576,632,000 USD
- Net income
- -562,539,000 USD
- Operating cash flow
- -497,934,000 USD